Home＞REGULATORY
Pharma Leaders Air Grievances on Pricing Reform Package at New MHLW Confab(Apr.17.2018)
Pharma industry leaders at public-private dialogue |
Chieftains of major drug makers and industry associations fired off a barrage of complaints against the 2018 drug pricing reform package at their new policy dialogue forum with senior health ministry officials on April 16, with Eisai CEO Hauro Naito warning that Japan is “sinking” as a drug discovery powerhouse ...
(LOG IN FOR FULL STORY)
-
- Recordati Succeeds Carbaglu Orphan Drug Designation from Pola Pharma Sep.20
- MHLW Orders Package Insert Revision for Xofigo, Warning of Increased Risk of Death, Bone Fracture with 3-Drug Combination Sep.20
- Pfizer to Use MID-NET Database for Ibrance PMS Sep.19
- Second Applicant from Pharma Companies to Use MID-NET: PMDA Sep.19
- Alexion’s PNH Therapy Ravulizumab, Two other APIs Bag Orphan Drug Designations Sep.19
- Astellas to Create New Business beyond Core Prescription Drug Business, Aims to Launch Several Products by FY2020(Sep.21)
- Opdivo Holds Promise as New Option for Malignant Pleural Mesothelioma: Pulmonary Specialist(Sep.21)
- Meiji Seika Pharma Commences Shipment of KM Biologics’ Flu Vaccine(Sep.21)
- Roxadustat Hit Goal in CKD Patients with Anemia Not on Dialysis in Multinational PIII Study: Astellas(Sep.21)
- Meiji Files Aricept Generic for Lewy Body Dementia to Win Full Indications(Sep.21)
